Chiron Investment Management LLC Acquires Shares of 5,000 Elanco Animal Health (ELAN)

Chiron Investment Management LLC acquired a new position in shares of Elanco Animal Health (NASDAQ:ELAN) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 5,000 shares of the company’s stock, valued at approximately $158,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Focused Wealth Management Inc purchased a new stake in Elanco Animal Health during the fourth quarter worth about $32,000. First Hawaiian Bank purchased a new position in shares of Elanco Animal Health in the fourth quarter worth about $35,000. Citigroup Inc. increased its stake in shares of Elanco Animal Health by 28.2% in the fourth quarter. Citigroup Inc. now owns 5,389 shares of the company’s stock worth $169,000 after purchasing an additional 1,187 shares in the last quarter. Krensavage Asset Management LLC increased its stake in shares of Elanco Animal Health by 0.7% in the fourth quarter. Krensavage Asset Management LLC now owns 201,362 shares of the company’s stock worth $6,162,000 after purchasing an additional 1,362 shares in the last quarter. Finally, American International Group Inc. purchased a new position in shares of Elanco Animal Health in the fourth quarter worth about $48,000.

In related news, Director R David Hoover bought 20,000 shares of the company’s stock in a transaction on Wednesday, March 13th. The stock was acquired at an average cost of $31.43 per share, for a total transaction of $628,600.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Several equities analysts have recently weighed in on ELAN shares. Argus started coverage on shares of Elanco Animal Health in a research note on Tuesday, January 15th. They issued a “buy” rating and a $37.00 target price for the company. Zacks Investment Research upgraded shares of Elanco Animal Health from a “hold” rating to a “buy” rating and set a $36.00 target price for the company in a research note on Monday, December 17th. Morgan Stanley started coverage on shares of Elanco Animal Health in a research note on Wednesday. They issued an “equal weight” rating and a $34.00 target price for the company. Credit Suisse Group restated a “hold” rating and issued a $36.00 price objective on shares of Elanco Animal Health in a research report on Monday, December 17th. Finally, BMO Capital Markets cut their price objective on shares of Elanco Animal Health from $37.00 to $32.00 and set a “market perform” rating for the company in a research report on Wednesday, December 19th. They noted that the move was a valuation call. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and five have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $33.48.

ELAN stock opened at $30.31 on Friday. Elanco Animal Health has a 12 month low of $28.00 and a 12 month high of $37.61.

Elanco Animal Health (NASDAQ:ELAN) last released its quarterly earnings data on Wednesday, February 6th. The company reported $0.29 EPS for the quarter, beating analysts’ consensus estimates of $0.26 by $0.03. The firm had revenue of $799.30 million during the quarter, compared to the consensus estimate of $804.07 million. During the same quarter last year, the business posted $0.12 earnings per share. Elanco Animal Health’s revenue was up 6.0% compared to the same quarter last year.

COPYRIGHT VIOLATION NOTICE: This article was published by Community Financial News and is owned by of Community Financial News. If you are reading this article on another website, it was stolen and reposted in violation of international trademark and copyright laws. The correct version of this article can be accessed at https://www.com-unik.info/2019/03/15/chiron-investment-management-llc-acquires-shares-of-5000-elanco-animal-health-elan.html.

About Elanco Animal Health

There is no company description available for Elanco Animal Health Inc

Read More: Stop Order Uses For Individual Investors

Want to see what other hedge funds are holding ELAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elanco Animal Health (NASDAQ:ELAN).

Institutional Ownership by Quarter for Elanco Animal Health (NASDAQ:ELAN)

Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.



Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit